TORIPALIMAB for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 40 adverse event reports in the FDA FAERS database where TORIPALIMAB was used for Breast cancer.
Most Reported Side Effects for TORIPALIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 590 | 43.9% | 3 | 432 |
| Off label use | 276 | 20.5% | 29 | 137 |
| White blood cell count decreased | 144 | 10.7% | 0 | 74 |
| Anaemia | 67 | 5.0% | 17 | 8 |
| Hypothyroidism | 67 | 5.0% | 13 | 11 |
| Neutrophil count decreased | 67 | 5.0% | 0 | 25 |
| Nausea | 60 | 4.5% | 7 | 14 |
| Rash | 59 | 4.4% | 7 | 11 |
| Vomiting | 58 | 4.3% | 7 | 14 |
| Platelet count decreased | 53 | 3.9% | 3 | 30 |
| Diarrhoea | 50 | 3.7% | 6 | 16 |
| Neutropenia | 49 | 3.7% | 8 | 1 |
| Thrombocytopenia | 48 | 3.6% | 12 | 0 |
| Pyrexia | 46 | 3.4% | 2 | 13 |
| Decreased appetite | 43 | 3.2% | 9 | 9 |
Other Indications for TORIPALIMAB
Nasopharyngeal cancer (163)
Hepatocellular carcinoma (125)
Oesophageal carcinoma (72)
Lung neoplasm malignant (65)
Malignant melanoma (36)
Small cell lung cancer (36)
Hepatic cancer (34)
Renal cancer (34)
Bladder cancer (33)
Oesophageal squamous cell carcinoma stage iv (29)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)